FARMACEUTICALRX is a vertically integrated medical marijuana operator focused on premium organic craft products. It cultivates cannabis using a living soil organic method and formulates condition-specific products including live resin vape, solvent-less products, RSO, and edibles. The company markets sub-brands in Ohio such as Burst of Wellness, TreePharm, Local Edibles, CannaRocks, and Open Mind (organic, vegan, gluten-free gummies). FRX holds licenses in Ohio and Pennsylvania and aims to expand reach across demographics at competitive price points. The company expects final organic certification in Q4 2022 and is led by founder and CEO Rebecca Myers alongside a team of scientists, healthcare, organic food and beverage, and cannabis industry professionals. KEY Investment Partners made a $1.5M investment and added a partner to FRX’s board, providing external capital support for the company’s growth plans and potential role in a future Ohio recreational market. FARMACEUTICALRX is one of the largest producers of premium organic medical marijuana products in the U.S. market and operates a vertically integrated platform. The company develops a suite of sub-branded products including Burst of Wellness vape products, TreePharm vape and RSO products, Local Edibles chocolates, and Open Mind organic, vegan, gluten-free gummies. FARMACEUTICALRX is licensed to offer medical marijuana in Pennsylvania and Ohio (combined population >26 million) and operates the FRX Health dispensary in East Liverpool, Ohio. It is expanding by completing a 100,000-square-foot Level 1 cultivation and post-harvest facility in East Liverpool and will bring cultivation and processing methods from its Pennsylvania operations. The company emphasizes R&D-driven product innovation and is led by CEO and founder Rebecca Myers. Recent financing is intended to support the Ohio expansion, equipment purchases, debt repayment, and general working capital as the company pursues revenue and profitability growth.

Total raised

$36M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2022